Covered recipient · General Payments record
ALBIO MOLINA CARNESOLTAS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2023–2024
$2,277.22
- Reported across 93 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,269.62 | 55 |
| Education | $199.98 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Incyte Corporation | $245.69 | 7 |
| Daiichi Sankyo Inc. | $141.45 | 5 |
| E.R. Squibb & Sons, L.L.C. | $135.34 | 8 |
| PFIZER INC. | $118.47 | 2 |
| Lilly USA, LLC | $113.50 | 4 |
| ABBVIE INC. | $80.72 | 3 |
| Janssen Biotech, Inc. | $65.58 | 2 |
| EISAI INC. | $57.68 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $56.29 | 3 |
| BeiGene USA, Inc. | $51.99 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $39.86 | 2 |
| Merck Sharp & Dohme Corporation | $33.93 | 1 |
| ARRAY BIOPHARMA INC | $33.03 | 1 |
| Astellas Pharma US Inc | $28.47 | 2 |
| Celgene Corporation | $27.21 | 1 |
| Stemline Therapeutics Inc. | $24.66 | 1 |
| Genmab U.S., Inc. | $24.03 | 1 |
| Dendreon Pharmaceuticals LLC | $23.46 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.64 | 1 |
| Gilead Sciences, Inc. | $21.61 | 1 |
| Adaptive Biotechnologies Corporation | $21.51 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $19.71 | 1 |
| Genentech USA, Inc. | $18.65 | 1 |
| Karyopharm Therapeutics Inc. | $18.48 | 1 |
| Acerta Pharma LLC | $15.62 | 1 |
| JAZZ PHARMACEUTICALS INC. | $15.61 | 1 |
| Alexion Pharmaceuticals, Inc. | $14.41 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (57)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.